TABLE 2.
Deceased (n = 32) | |
Male gender | 16 (50.0%) |
Age, median (IQR) | 6 Years (177 days–15.5 years) |
Age groups | |
0–6 days | 4 (12.5%) |
7 days to less than 3 months | 1 (3.1%) |
3 months to less than 2 years | 8 (25.0%) |
2–9 years | 5 (15.6%) |
10–13 years | 2 (6.3%) |
14–17 years | 12 (37.5%) |
Underlying medical condition | |
Respiratory disease | 10 (31.3%) |
Asthma | 4 (12.5%) |
Chronic lung disease excluding asthma | 6 (18.8%) |
Metabolic disease | 7 (21.9%) |
Diabetes | 0 |
Metabolic disease excluding diabetes | 7 (21.9%) |
Sickle-cell disease | 0 |
Obesity | 1 (3.1%) |
Cardiovascular disease | 5 (15.6%) |
Neurologic disease | 19 (59.4%) |
Immunocompromised condition (including cancers) | 6 (18.8%) |
Hepatic and gastric disease | 0 |
Renal disease | 0 |
Down syndrome | 0 |
Prematurity among < 2 years (n = 3868) | 5 (38.5%) |
Number of underlying conditions | |
0 | 4 (12.5%) |
1 | 13 (40.6%) |
2 | 8 (25.0%) |
3 Or more | 7 (21.9%) |
COVID-19 forms | |
PIMS | 1 (3.1%) |
Respiratory form | 25 (78.1%) |
No PIMS no respiratory form | 6 (18.8%) |
Level of care required | |
Admission in critical care unit | 25 (78.1%) |
Ventilation | 23 (71.9%) |
Invasive ventilation | 20 (62.5%) |
Non-invasive ventilation | 9 (28.1%) |
ECMO | 4 (12.5%) |
Need of vasoactive drugs | 12 (37.5%) |
Hospital length of stay, median (IQR), days | 8 (2–20.5) |
IQR, interquartile range; CCU, critical care unit; ECMO, extracorporeal membrane oxygenation; PIMS, pediatric multisystem inflammatory syndrome.